posted on 2017-02-14, 00:00authored byJoel R. Walker, Mary P. Hall, Chad A. Zimprich, Matthew B. Robers, Sarah J. Duellman, Thomas Machleidt, Jacquelynn Rodriguez, Wenhui Zhou
Novel
engineered NanoLuc (Nluc) luciferase being smaller, brighter,
and superior to traditional firefly (Fluc) or Renilla (Rluc) provides a great opportunity for the development of numerous
biological, biomedical, clinical, and food and environmental safety
applications. This new platform created an urgent need for Nluc inhibitors
that could allow selective bioluminescent suppression and multiplexing
compatibility with existing luminescence or fluorescence assays. Starting
from thienopyrrole carboxylate 1, a hit from a 42 000
PubChem compound library with a low micromolar IC50 against
Nluc, we derivatized four different structural fragments to discover
a family of potent, single digit nanomolar, cell permeable inhibitors.
Further elaboration revealed a channel that allowed access to the
external Nluc surface, resulting in a series of highly potent cell
impermeable Nluc inhibitors with negatively charged groups likely
extending to the protein surface. The permeability was evaluated by
comparing EC50 shifts calculated from both live and lysed
cells expressing Nluc cytosolically. Luminescence imaging further
confirmed that cell permeable compounds inhibit both intracellular
and extracellular Nluc, whereas less permeable compounds differentially
inhibit extracellular Nluc and Nluc on the cell surface. The compounds
displayed little to no toxicity to cells and high luciferase specificity,
showing no activity against firefly luciferase or even the closely
related NanoBit system. Looking forward, the structural motifs used
to gain access to the Nluc surface can also be appended with other
functional groups, and therefore interesting opportunities for developing
assays based on relief-of-inhibition can be envisioned.